Compound information
- Natural Products
- ZC810432
- Molecular Formula
- C14H16N4OS
- Molecular Weight
- 288.104482132 g/mol
- Structure
-
- IUPAC Name
- N-phenyl-4-thiazol-2-yl-piperazine-1-carboxamide
- InChI
- InChI=1S/C14H16N4OS/c19-13(16-12-4-2-1-3-5-12)17-7-9-18(10-8-17)14-15-6-11-20-14/h1-6,11H,7-10H2,(H,16,19)
- InChI Key
- OSNAOEUXHMYALS-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccccc1)N1CCN(c2nccs2)CC1
- Source
- ZINC000010259155
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.248 |
LogS | -3.634 | LogD | 2.813 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.046 | Pgp substrate | 0.74 |
HIA | 0.964 | F20 % | 0.994 |
F30 % | 0.906 | Caco-2 | -4.725 |
MDCK | -4.93 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.115 | PPB | 96.01 |
VD | 0.548 | Fu | 1.26 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.661 |
CYP2A6 substrate | 0.571 | CYP2B6 substrate | 0.656 |
CYP2C19 inhibitor | 0.876 | CYP2C19 substrate | 0.672 |
CYP2C8 substrate | 0.662 | CYP2C9 inhibitor | 0.894 |
CYP2C9 substrate | 0.632 | CYP2D6 inhibitor | 0.321 |
CYP2D6 substrate | 0.978 | CYP2E1 substrate | 0.812 |
CYP3A4 inhibitor | 0.058 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.787 | CL | 2.556 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.389 | Hepatotoxicity | 0.473 |
Mutagenicity | 0.032 | Rat Oral Acute Toxicity | 0.505 |
FDAMDD | 0.231 | Skin Sensitization | 0.993 |
Carcinogenicity | 0.944 | Eye Corrosion | 0.003 |
Eye Irritation | 0.041 | Respiratory Toxicity | 0.949 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.147 | IGC50 | 2.293 |
LC50FM | 1.322 | LC50DM | -5.233 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.406 | NR-AR-LBD | 0.198 |
NR-AhR | 0.753 | NR-Aromatase | 0.026 |
NR-ER | 0.677 | NR-ER-LBD | 0.326 |
NR-PPAR-gamma | 0.294 | SR-ARE | 0.85 |
SR-ATAD5 | 0.706 | SR-HSE | 0.166 |
SR-MMP | 0.093 | SR-p53 | 0.111 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.